NCT02886533View on ClinicalTrials.gov

Major Bleeding Risk Associated With Antithrombotics

CompletedOBSERVATIONAL
Enrollment

6,484

Participants

Timeline

Start Date

January 1, 2013

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions
Major Haemorrhage
Interventions
OTHER

Antithrombotic

Collection of clinical, biological data

Trial Locations (12)

35033

CHU de Rennes, Rennes

35576

Hôpital Privé Sévigné, Cesson-Sévigné

35768

Centre Hospitalier Privé, Saint-Grégoire

38028

Groupe Hospitalier Mutualiste, Grenoble

38043

CHU de Grenoble, Grenoble

38432

Clinique des Cèdres, Échirolles

44093

CHU de Nantes, Nantes

44277

Nouvelles Cliniques Nantaises, Nantes

49000

Clinique de l'Anjou, Angers

49033

CHU d'Angers, Angers

29 240

Hôpital Inter-Armées, Brest

29 609

CHU de Brest, Brest

All Listed Sponsors
lead

Rennes University Hospital

OTHER

NCT02886533 - Major Bleeding Risk Associated With Antithrombotics | Biotech Hunter | Biotech Hunter